Market News Archive
Stay updated with the latest announcements
SALVOCHEM: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 05, 2025 at 3:00 PM to consider, among others, Un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2025.
ORIONINFU: Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 09, 2025 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2025.
OIMEX: Reschedule of Board Meeting under LR 19(1)
The Company has further informed that the meeting of the Board of Directors of the Company as per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will be held on November 04, 2025 at 6:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2025.
SICL: Auditor's report regarding status of IPO Proceeds utilization
Sikder Insurance Company Limited submitted auditor's report regarding "Status of IPO (Initial Public Offering) Proceeds utilization statement" for the period from July?01,?2025 to September?30,?2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/Sikder-Insurance-Co.Ltd-2025.pdf
SILVAPHL: Auditor's report regarding status of IPO Proceeds utilization
Silva Pharmaceuticals Limited submitted auditor's report regarding "Status of IPO (Initial Public Offering) Proceeds utilization statement" for the month ended September?30,?2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/Silva-Pharmaceuticals-Ltd-2025.pdf
TECHNODRUG: Auditor's report regarding status of IPO Proceeds utilization
Techno Drugs Limited submitted auditor's report regarding "Status of IPO (Initial Public Offering) Proceeds utilization statement" for the quarter ended September?30,?2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/Techno-Drugs-Ltd-2025.pdf
ACFL: Auditor's report regarding status of IPO Proceeds utilization
Aman Cotton Fibrous Limited submitted auditor's report regarding "Status of IPO (Initial Public Offering) Proceeds utilization statement" for the month of September?30,?2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/AmanCotton_2025.pdf
NAVANAPHAR: Auditor's report regarding status of IPO Proceeds utilization
Navana Pharmaceuticals PLC submitted auditor's report regarding "Status of IPO (Initial Public Offering) Proceeds utilization statement" for the quarter ended September?30,?2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/Navana-Pharma-ceuticals-PLC-2025.pdf
NTLTUBES: Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 06, 2025 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2025.
FINEFOODS: Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 06, 2025 at 4:30 PM to consider, among others, Un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2025.
JHRML: Auditor's report regarding status of IPO Proceeds utilization
JMI Hospital Requisite Manufacturing Limited submitted auditor's report regarding status of IPO (Initial Public Offering) Proceeds utilization statement for the period from July 01, 2025 to September 30, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/JHRML_112025.pdf
INDEXAGRO: Qualified Opinion and Emphasis of Matter
The auditor of the company has given the "Qualified Opinion" and "Emphasis of Matter" paragraph in the Auditor's Report of the company for the year ended June 30, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/INDEXAGRO_112025.pdf
MONNOCERA: Qualified Opinion and Emphasis of Matter
The auditor of the company has given the "Qualified Opinion" and "Emphasis of Matter" paragraph in the Auditor's Report of the company for the year ended June 30, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/MONNOCERA_112025.pdf
KOHINOOR: Emphasis of Matter
The auditor of the company has given the "Emphasis of Matter" paragraph in the Auditor's Report of the company for the year ended June 30, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/KOHINOOR_112025.pdf
APEXFOOT: Qualified Opinion
The auditor of the company has given the "Qualified Opinion" in the Auditor's Report of the company for the year ended June 30, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/APEXFOOT_112025.pdf
TB15Y0526: Record date for entitlement of coupon payment
Record date for entitlement of coupon payment of 15Y BGTB 11/05/2026 Government Securities is 10.11.2025.
BDLAMPS: Suspension for Record date
Trading of the shares of the company will remain suspended on record date i.e., 03.11.2025.
NPOLYMER: Dividend Declaration (Additional Information)
Refer to their earlier news disseminated by DSE on 26.10.2025 regarding dividend declaration, the company has further informed that the Board of Directors has recommended the 5% cash dividend (excluding the Sponsors) from the Company's retained earnings. The declared cash dividend has not been recommended from the capital reserve or revaluation reserve or any unrealized gain of the company or through reducing the paid-up capital
MERCANBANK: Sale confirmation of a Sponsor
Mr. Md. Mizanur Rahman Chowdhury, a Sponsor of the company, has completed his sale of 1,89,000 shares of the Company at prevailing market price through Dhaka Stock Exchange PLC. as per declaration disseminated by DSE on 07.10.2025.
SEMLFBSLGF: Weekly NAV
On the close of operation on 30-Oct-2025, the Fund has reported Net Asset Value (NAV) of Tk. 9.42 per unit on the basis of current market price and Tk. 11.15 per unit on the basis of cost price against face value of Tk. 10.00 whereas total Net Assets of the Fund stood at Tk. 687,114,549.19 on the basis of current market price and Tk. 813,342,975.87 on the basis of cost price after considering all assets and liabilities of the Fund.